IGF1 and metabolic dysfunction-associated steatohepatitis: Lastly, the performance of the proposed biomarker panels comprising serum adiponectin and lipids for NAFL vs. NASH stratification and serum IGF-1 with INR and ferritin for identification of advanced fibrosis should be prospectively tested in a different cohort.